Ibrutinib for Chronic Graft-Versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2019.06.023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Phase I/2 Study of Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis After Allogeneic Transplantation (alloHCT).

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Response to Thalidomide Therapy in Refractory Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Topical Corticosteroid Therapy for Cicatricial Conjunctivitis Associated With Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2004English

Genital Chronic Graft-Versus-Host Disease in Females: A Cross-Sectional Study

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Treatment of Chronic Graft-Versus-Host Disease in 2011

Current Opinion in Hematology
Hematology
2011English

Acute and Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

Revista da Associacao Medica Brasileira
Medicine
2016English

Feasibility of NIH Consensus Criteria for Chronic Graft-Versus-Host Disease

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Lymphocyte Dysfunction in Chronic Graft-Versus-Host Disease

Blood
BiochemistryImmunologyCell BiologyHematology
1981English

An Investigator Initiated Phase II Clinical Trial of Tamibarotene (AM80G) for Chronic Graft-Versus-Host Disease

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy